Copyright
©The Author(s) 2004.
World J Gastroenterol. Feb 15, 2004; 10(4): 583-585
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.583
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.583
Table 1 Sex of patients, grade of malignancy (G) and pT stage
| Inoperable tumours | G2 pT2 | G2 pT3 | G2 pT4 | G3 pT3 | G3 pT4 | All | |
| Women | 4 | 4 | 23 | 5 | 10 | 0 | 46 |
| 33.33% | 44.44% | 40.35% | 41.67% | 52.63% | 0.00% | 40.35% | |
| Men | 8 | 5 | 34 | 7 | 9 | 5 | 68 |
| 66.67% | 55.56% | 59.65% | 58.33% | 47.37% | 100.00% | 59.65% | |
| All | 12 | 9 | 57 | 12 | 19 | 5 | 114 |
| 10.53% | 7.89% | 50.00% | 10.53% | 16.67% | 4.39% | 100.00% |
- Citation: Zalewski B. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World J Gastroenterol 2004; 10(4): 583-585
- URL: https://www.wjgnet.com/1007-9327/full/v10/i4/583.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i4.583